Search

Search Constraints

You searched for: Author/Creator Garnier, Marc

Search Results

1. Human airway trypsin‐like protease exerts potent, antifibrotic action in pulmonary fibrosis. Issue 3 (3rd January 2018)

2. Multicentre randomised controlled trial to investigate usefulness of the rapid diagnostic βLACTA test performed directly on bacterial cell pellets from respiratory, urinary or blood samples for the early de-escalation of carbapenems in septic intensive care unit patients: the BLUE-CarbA protocol. Issue 2 (3rd February 2019)

3. Multicentre randomised controlled trial to investigate usefulness of the rapid diagnostic βLACTA test performed directly on bacterial cell pellets from respiratory, urinary or blood samples for the early de-escalation of carbapenems in septic intensive care unit patients: the BLUE-CarbA protocol. Issue 2 (3rd February 2019)

4. Delayed inflammation decrease is associated with mortality in Tocilizumab-treated critically ill SARS-CoV-2 patients: A retrospective matched-cohort analysis. Issue 1 (January 2022)

6. Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial. (January 2022)

7. Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial. Issue 2 (February 2022)

9. Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial. Issue 3 (March 2021)

10. Macrophage Polarization Favors Epithelial Repair During Acute Respiratory Distress Syndrome*. Issue 7 (July 2018)